Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Esculentins extracted from plant and found to exert antiinflammatory, antitumor effects

Sep. 21, 2000

2-5A antisense compound effective against malignant glioma and prostate cancer in mice

Sep. 21, 2000

Photofrin effective in treatment of Barrett's esophagus-related dysplasia

Sep. 21, 2000

BLA resubmitted for Bexxar

Sep. 21, 2000

Matrix metalloproteinase-inhibitory compounds described in recent patent

Sep. 20, 2000

uPAR antagonists claimed by Roche Diagnostics as antitumor/antimetastatic agents

Sep. 20, 2000

Phase I Oncolym study begins for relapsed and refractory B-cell lymphoma

Sep. 19, 2000

Combination 2ME2 and Taxotere trial begins

Sep. 19, 2000

Japanese lab identifies benzimidazole-based antitumor agents

Sep. 18, 2000

Kirin Brewery investigates antitumor activity of quinoline and quinazoline derivatives

Sep. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...